Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Lindsey Dayer

TitleAssociate Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentExperiential Education, College of Pharmacy
DivisionExperiential Education
Address6/110B ED II
320 UAMS Campus Dr.
Mail Slot # 522
Little Rock AR 72205
Phone501-526-4211
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Painter JT, Peng C, Burlette M, Clement C, Luciani L, Azhar G, Dayer L. The Effect of Concurrent Use of Opioids and Gabapentin on Fall Risk in Older Adults. J Pain Palliat Care Pharmacother. 2024 Jun 10; 1-7. PMID: 38857121.
      View in: PubMed
    2. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations. Pain Med. 2024 Mar 01; 25(3):173-186. PMID: 38243702.
      View in: PubMed
    3. Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors. Clin Breast Cancer. 2023 08; 23(6):598-619. PMID: 37328334.
      View in: PubMed
    4. Choi AN, Dayer LE, Stafford RA, Dunn EB, Li C. Prior Pharmacy Work Experience as a Predictor of Clinical and Didactic Performance for Admissions Committees. Am J Pharm Educ. 2023 05; 87(5):100053. PMID: 37288688.
      View in: PubMed
    5. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients. Clin J Pain. 2023 Mar 01; 39(3):107-118. PMID: 36728675.
      View in: PubMed
    6. Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain. J Cancer Surviv. 2024 Jun; 18(3):917-927. PMID: 36753003.
      View in: PubMed
    7. Riley E, Trotter S, Dayer L, Teigen A, Nagel C, Stickley K, LaBorde P, Richardson L, McFerguson R, Ward N, Anders M. Interprofessional Naloxone Student Training to Manage Suspected Opioid Overdose. Clin Nurse Spec. 2023 Jan-Feb 01; 37(1):26-35. PMID: 36508232.
      View in: PubMed
    8. Creighton EW, Dayer L, King D, Vural E, Sunde J, Moreno MA, Stack BC. Remote smart pill cap monitoring of post-surgical pain management in thyroid and parathyroid surgery. Am J Surg. 2023 06; 225(6):988-993. PMID: 36639303.
      View in: PubMed
    9. Dayer LE, Wagner R, King D, Lakkad M, Wilson LA, Montgomery C, Painter JT. Impact of Hydroxyurea Starting Dose on Pain Outcomes in Patients with Sickle Cell Disease. J Pain Palliat Care Pharmacother. 2022 Dec; 36(4):223-227. PMID: 36688614.
      View in: PubMed
    10. Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data. J Cancer Surviv. 2023 08; 17(4):917-950. PMID: 36369622.
      View in: PubMed
    11. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas. Curr Med Res Opin. 2022 11; 38(11):1947-1957. PMID: 36000252.
      View in: PubMed
    12. Callaway K, Lakkad M, Painter JT, Dayer L, Oswalt AK. The Impact of Continuous Infusion Compared to Intravenous Bolus Administration of Pantoprazole on Length of Intensive Care Unit Stay in Critically Ill Patients. J Pharm Pract. 2023 Apr; 36(2):276-280. PMID: 34376087.
      View in: PubMed
    13. Dragic L, Webb T, Chandler M, Harrington SB, McDade E, Dayer L, Painter JT. Comparing Effectiveness of Gabapentin and Pregabalin in Treatment of Neuropathic Pain: A Retrospective Cohort of Palliative Care Outpatients. J Pain Palliat Care Pharmacother. 2020 Dec; 34(4):192-196. PMID: 32924715.
      View in: PubMed
    14. Pritchard ER, Dayer L, Belz J, Forseth B, Harrington SE, Painter JT. Effect of cannabis on opioid use in patients with cancer receiving palliative care. J Am Pharm Assoc (2003). 2020 Jan - Feb; 60(1):244-247. PMID: 31843373.
      View in: PubMed
    15. Dayer LE, Breckling MN, Kling BS, Lakkad M, McDade ER, Painter JT. Association of the "CDC Guideline for Prescribing Opioids for Chronic Pain" With Emergency Department Opioid Prescribing. J Emerg Med. 2019 11; 57(5):597-602. PMID: 31594747.
      View in: PubMed
    16. Dayer LE, McDade ER, Harrington S. Pharmacist-Delivered Patient Care in an Interdisciplinary Team-Based Institutional Palliative Care Clinic, 2012 to 2018. J Palliat Care. 2021 Jul; 36(3):188-193. PMID: 31496358.
      View in: PubMed
    17. Dayer LE, Painter JT, McCain K, King J, Cullen J, Foster HR. A recent history of opioid use in the US: Three decades of change. Subst Use Misuse. 2019; 54(2):331-339. PMID: 30572776.
      View in: PubMed
    18. Heldenbrand SD, Dayer LE, Martin BC, O'Brien C, Choi AN, Gubbins PO, Hawthorne J, Ramey M, Willis K, Flowers SK. APPE Evaluations are Positively Associated with MMI, Pre-pharmacy GPA and Pharmacy GPA. Am J Pharm Educ. 2018 09; 82(7):6326. PMID: 30323388.
      View in: PubMed
    19. Dayer LE, Shilling R, Van Valkenburg M, Martin BC, Gubbins PO, Hadden K, Heldenbrand S. Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points. JMIR Mhealth Uhealth. 2017 Apr 19; 5(4):e45. PMID: 28428169.
      View in: PubMed
    20. Heldenbrand S, Martin BC, Gubbins PO, Hadden K, Renna C, Shilling R, Dayer L. Assessment of medication adherence app features, functionality, and health literacy level and the creation of a searchable Web-based adherence app resource for health care professionals and patients. J Am Pharm Assoc (2003). 2016 May-Jun; 56(3):293-302. PMID: 27067551.
      View in: PubMed
    21. Dayer L, Dunn E, Pace A, Flowers S. Pharmacists' perceived knowledge of and confidence in dispensing oral antineoplastic agents. J Am Pharm Assoc (2003). 2016 Mar-Apr; 56(2):141-4.e2. PMID: 27000164.
      View in: PubMed
    22. Dayer L, Harrington S, Martin B. Adherence to Adjuvant Neuropathic Pain Medications in a Palliative Care Clinic. J Palliat Med. 2016 05; 19(5):538-41. PMID: 26835743.
      View in: PubMed
    23. Dayer LE, Hutchins LF, Johnson JT. Treatment of metastatic melanoma with pazopanib: A report of five patient cases. J Oncol Pharm Pract. 2015 Jun; 21(3):224-31. PMID: 24576945.
      View in: PubMed
    24. Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps: potential benefits to patients and providers: response to Aungst. J Am Pharm Assoc (2003). 2013 Jul-Aug; 53(4):345. PMID: 23892801.
      View in: PubMed
    25. Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc (2003). 2013 Mar-Apr; 53(2):172-81. PMID: 23571625.
      View in: PubMed
    Dayer's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description